News & Features — Infensa Bioscience

Features

Features

Infensa’s drug versus current cardiovascular treatments: what’s the difference?

Infensa’s drug versus current cardiovascular treatments: what’s the difference?

How to succeed in biotech: thoughts from our CEO

How to succeed in biotech: thoughts from our CEO

Profiles

Profiles

Profile: Michael Ankersen

Profile: Mark Smythe

Profile: Bob Graham AO

News

2025

News blog

National recognition for cardiovascular research translation

Feb 21, 2025

National recognition for cardiovascular research translation

Feb 21, 2025

Feb 21, 2025

News blog

Infensa researchers nominated for a national university award

Oct 10, 2024

Infensa researchers nominated for a national university award

Oct 10, 2024

Oct 10, 2024

Infensa drug candidate receives $17.8M funding to advance to clinical trials

Oct 7, 2024

Infensa drug candidate receives $17.8M funding to advance to clinical trials

Oct 7, 2024

Oct 7, 2024

Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards

Aug 30, 2024

Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards

Aug 30, 2024

Aug 30, 2024

Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland

Jul 30, 2024

Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland

Jul 30, 2024

Jul 30, 2024

Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science

May 23, 2024

Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science

May 23, 2024

May 23, 2024

Brisbane startup Infensa spins medical miracle from spider venom

Mar 5, 2024

Brisbane startup Infensa spins medical miracle from spider venom

Mar 5, 2024

Mar 5, 2024

2024

2023

News blog

Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction

Dec 14, 2023

Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction

Dec 14, 2023

Dec 14, 2023

Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry

Nov 17, 2023

Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry

Nov 17, 2023

Nov 17, 2023

Infensa CSO and co-founder Professor Glenn King received the Prime Minster’s Prize for Innovation, the highest honour for science translation in Australia

Oct 16, 2023

Infensa CSO and co-founder Professor Glenn King received the Prime Minster’s Prize for Innovation, the highest honour for science translation in Australia

Oct 16, 2023

Oct 16, 2023

2022

News blog

The Translational Research Institute welcomes new startup Infensa Bioscience

Jul 7, 2022

The Translational Research Institute welcomes new startup Infensa Bioscience

Jul 7, 2022

Jul 7, 2022

Australian Financial Review: Aussie start-up using funnel web venom to save lives scores $23 million

Jul 4, 2022

Australian Financial Review: Aussie start-up using funnel web venom to save lives scores $23 million

Jul 4, 2022

Jul 4, 2022

2021

Featured

Fraser Island funnel web spider venom shows promise for heart-attack treatment

Jul 29, 2021

Fraser Island funnel web spider venom shows promise for heart-attack treatment

Jul 29, 2021

Jul 29, 2021

Deadly spider’s venom could someday help heart attack victims, Australian scientists say</span>

Jul 20, 2021

Deadly spider’s venom could someday help heart attack victims, Australian scientists say

Jul 20, 2021

Jul 20, 2021

Deadly venom from funnel-web spider found only in Queensland could contain life-saving heart attack treatment

Jul 16, 2021

Deadly venom from funnel-web spider found only in Queensland could contain life-saving heart attack treatment

Jul 16, 2021

Jul 16, 2021

Death disruptor: how an Australian funnel-web spider may help human hearts</span>

Jul 16, 2021

Death disruptor: how an Australian funnel-web spider may help human hearts

Jul 16, 2021

Jul 16, 2021

One of the world's deadliest spider venoms could help heart attack patients </span>

Jul 16, 2021

One of the world's deadliest spider venoms could help heart attack patients

Jul 16, 2021

Jul 16, 2021

Aussie scientists see life-saving potential in spider venom

Jul 16, 2021

Aussie scientists see life-saving potential in spider venom

Jul 16, 2021

Jul 16, 2021

Stopping 'death signal': Scientists look to repair hearts using deadly spider venom

Jul 16, 2021

Stopping 'death signal': Scientists look to repair hearts using deadly spider venom

Jul 16, 2021

Jul 16, 2021

Infensa scientists show efficacy of lead drug candidate in preclinical models of myocardial infarction and heart transplantation</span>

Jul 15, 2021

Infensa scientists show efficacy of lead drug candidate in preclinical models of myocardial infarction and heart transplantation

Jul 15, 2021

Jul 15, 2021